Trial Outcomes & Findings for Data on the Impact of Different Treatment on the Quality of Life of Patients With Acute and Chronic Hemorrhoid Disease (NCT NCT03743311)

NCT ID: NCT03743311

Last Updated: 2021-03-29

Results Overview

The Short Form (36) Health Survey (SF36 ) scale questioner was used. SF36 is is a 36-item, patient-reported survey of patient health. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.

Recruitment status

COMPLETED

Target enrollment

1032 participants

Primary outcome timeframe

1 month after presenting to a doctor

Results posted on

2021-03-29

Participant Flow

Participant milestones

Participant milestones
Measure
Conservative Treatment of Hemmorhoid
Patients taken conservative treatment (Detralex) Detralex: Conservative treatment of Hemorhoid
Combined Treatment of Hemmorhoid
Combined treatment patients (surgery and conservative treatment) Combined therapy: Surgical + conservative treatment of Hemorhoid
Surgical Treatment of Hemmorhoid
Patients after surgical treatment (Instrumental Invasive Surgical Procedures or Thrombectomy, Hemorrhoidectomy etc.) Hemorrhoidectomy, Thrombectomy , Operation on Longo method: Surgical procedures for treatment of Hemorhoid
Overall Study
STARTED
311
298
423
Overall Study
COMPLETED
311
298
423
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

There is no data about sex of 2 participants in Group 1 There is no data about sex of 3 participants in Group 3

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Conservative Treatment of Hemmorhoid
n=311 Participants
Patients taken conservative treatment (Detralex) Detralex: Conservative treatment of Hemorhoid
Combined Treatment of Hemmorhoid
n=298 Participants
Combined treatment patients (surgery and conservative treatment) Combined therapy: Surgical + conservative treatment of Hemorhoid
Surgical Treatment of Hemmorhoid
n=423 Participants
Patients after surgical treatment (Instrumental Invasive Surgical Procedures or Thrombectomy, Hemorrhoidectomy etc.) Hemorrhoidectomy, Thrombectomy , Operation on Longo method: Surgical procedures for treatment of Hemorhoid
Total
n=1032 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=311 Participants
0 Participants
n=298 Participants
0 Participants
n=423 Participants
0 Participants
n=1032 Participants
Age, Categorical
Between 18 and 65 years
289 Participants
n=311 Participants
274 Participants
n=298 Participants
396 Participants
n=423 Participants
959 Participants
n=1032 Participants
Age, Categorical
>=65 years
22 Participants
n=311 Participants
24 Participants
n=298 Participants
27 Participants
n=423 Participants
73 Participants
n=1032 Participants
Age, Continuous
42.9 years
n=311 Participants
44.2 years
n=298 Participants
46.9 years
n=423 Participants
44.9 years
n=1032 Participants
Sex: Female, Male
Female
171 Participants
n=309 Participants • There is no data about sex of 2 participants in Group 1 There is no data about sex of 3 participants in Group 3
139 Participants
n=298 Participants • There is no data about sex of 2 participants in Group 1 There is no data about sex of 3 participants in Group 3
209 Participants
n=420 Participants • There is no data about sex of 2 participants in Group 1 There is no data about sex of 3 participants in Group 3
519 Participants
n=1027 Participants • There is no data about sex of 2 participants in Group 1 There is no data about sex of 3 participants in Group 3
Sex: Female, Male
Male
138 Participants
n=309 Participants • There is no data about sex of 2 participants in Group 1 There is no data about sex of 3 participants in Group 3
159 Participants
n=298 Participants • There is no data about sex of 2 participants in Group 1 There is no data about sex of 3 participants in Group 3
211 Participants
n=420 Participants • There is no data about sex of 2 participants in Group 1 There is no data about sex of 3 participants in Group 3
508 Participants
n=1027 Participants • There is no data about sex of 2 participants in Group 1 There is no data about sex of 3 participants in Group 3
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
Russia
311 Participants
n=311 Participants
298 Participants
n=298 Participants
423 Participants
n=423 Participants
1032 Participants
n=1032 Participants
patients with acute or chronic hemorrhoids
311 Participants
n=311 Participants
298 Participants
n=298 Participants
423 Participants
n=423 Participants
1032 Participants
n=1032 Participants

PRIMARY outcome

Timeframe: 1 month after presenting to a doctor

The Short Form (36) Health Survey (SF36 ) scale questioner was used. SF36 is is a 36-item, patient-reported survey of patient health. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.

Outcome measures

Outcome measures
Measure
Surgical Treatment of Hemmorhoid
n=311 Participants
Patients after surgical treatment (Instrumental Invasive Surgical Procedures or Thrombectomy, Hemorrhoidectomy etc.) Hemorrhoidectomy, Thrombectomy , Operation on Longo method: Surgical procedures for treatment of Hemorhoid
Conservative Treatment of Hemmorhoid
n=298 Participants
Patients taken conservative treatment (Detralex) Detralex: Conservative treatment of Hemorhoid
Combined Treatment of Hemmorhoid
n=423 Participants
Combined treatment patients (surgery and conservative treatment) Combined therapy: Surgical + conservative treatment of Hemorhoid
Changes in the Quality of Life of Patients Suffering From Acute or Chronic Hemorrhoids Within 1 Month After Presenting to a Doctor (Visit V0 vs Visit3)
Physical functioning
16.5 units on a scale
Interval 3.4 to 29.6
11.1 units on a scale
Interval 2.7 to 19.5
13.7 units on a scale
Interval 6.4 to 21.0
Changes in the Quality of Life of Patients Suffering From Acute or Chronic Hemorrhoids Within 1 Month After Presenting to a Doctor (Visit V0 vs Visit3)
Role physical
15.5 units on a scale
Interval 10.0 to 21.0
6.5 units on a scale
Interval 3.8 to 9.2
6.3 units on a scale
Interval 6.0 to 6.6
Changes in the Quality of Life of Patients Suffering From Acute or Chronic Hemorrhoids Within 1 Month After Presenting to a Doctor (Visit V0 vs Visit3)
Bodily pain
19.8 units on a scale
Interval 13.2 to 26.4
3.9 units on a scale
Interval 0.5 to 7.3
1.8 units on a scale
Interval 1.0 to 4.6
Changes in the Quality of Life of Patients Suffering From Acute or Chronic Hemorrhoids Within 1 Month After Presenting to a Doctor (Visit V0 vs Visit3)
General health
13 units on a scale
Interval 6.4 to 19.6
9.7 units on a scale
Interval 8.2 to 11.2
11.6 units on a scale
Interval 9.1 to 14.1
Changes in the Quality of Life of Patients Suffering From Acute or Chronic Hemorrhoids Within 1 Month After Presenting to a Doctor (Visit V0 vs Visit3)
Vitality
7.2 units on a scale
Interval 5.0 to 9.4
3.9 units on a scale
Interval 2.2 to 5.6
6.5 units on a scale
Interval 4.9 to 8.1
Changes in the Quality of Life of Patients Suffering From Acute or Chronic Hemorrhoids Within 1 Month After Presenting to a Doctor (Visit V0 vs Visit3)
Social functioning
18.4 units on a scale
Interval 9.2 to 27.6
10.4 units on a scale
Interval 5.2 to 15.6
8.2 units on a scale
Interval 5.3 to 11.1
Changes in the Quality of Life of Patients Suffering From Acute or Chronic Hemorrhoids Within 1 Month After Presenting to a Doctor (Visit V0 vs Visit3)
Role emotional
30.4 units on a scale
Interval 17.9 to 42.9
12.8 units on a scale
Interval 5.5 to 18.5
11.4 units on a scale
Interval 8.5 to 14.3
Changes in the Quality of Life of Patients Suffering From Acute or Chronic Hemorrhoids Within 1 Month After Presenting to a Doctor (Visit V0 vs Visit3)
Mental health
14.4 units on a scale
Interval 8.3 to 20.5
8.7 units on a scale
Interval 5.6 to 11.8
11 units on a scale
Interval 6.3 to 15.7

PRIMARY outcome

Timeframe: 1 month after presenting to a doctor

QoL assessment using the SF36 scale questioner ( assessment of QoL quastions) - added to the Referance The Short Form (36) Health Survey (SF36 ) scale questioner was used. SF36 is is a 36-item, patient-reported survey of patient health. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.

Outcome measures

Outcome measures
Measure
Surgical Treatment of Hemmorhoid
n=1032 Participants
Patients after surgical treatment (Instrumental Invasive Surgical Procedures or Thrombectomy, Hemorrhoidectomy etc.) Hemorrhoidectomy, Thrombectomy , Operation on Longo method: Surgical procedures for treatment of Hemorhoid
Conservative Treatment of Hemmorhoid
Patients taken conservative treatment (Detralex) Detralex: Conservative treatment of Hemorhoid
Combined Treatment of Hemmorhoid
Combined treatment patients (surgery and conservative treatment) Combined therapy: Surgical + conservative treatment of Hemorhoid
Changes in the Quality of Life During the Treatment (Visit V0 vs Visit V3) Based on Results of All Groups of Patients
Physical functioning
13.8 units on a scale
Interval 5.6 to 22.0
Changes in the Quality of Life During the Treatment (Visit V0 vs Visit V3) Based on Results of All Groups of Patients
Role physical
9.2 units on a scale
Interval 7.6 to 10.8
Changes in the Quality of Life During the Treatment (Visit V0 vs Visit V3) Based on Results of All Groups of Patients
Bodily pain
8.8 units on a scale
Interval 5.4 to 12.2
Changes in the Quality of Life During the Treatment (Visit V0 vs Visit V3) Based on Results of All Groups of Patients
General health
11.5 units on a scale
Interval 8.9 to 14.1
Changes in the Quality of Life During the Treatment (Visit V0 vs Visit V3) Based on Results of All Groups of Patients
Vitality
6 units on a scale
Interval 4.1 to 7.9
Changes in the Quality of Life During the Treatment (Visit V0 vs Visit V3) Based on Results of All Groups of Patients
Social functioning
12 units on a scale
Interval 6.8 to 17.2
Changes in the Quality of Life During the Treatment (Visit V0 vs Visit V3) Based on Results of All Groups of Patients
Mental health
11.4 units on a scale
Interval 6.7 to 16.1
Changes in the Quality of Life During the Treatment (Visit V0 vs Visit V3) Based on Results of All Groups of Patients
Role emotional
17.5 units on a scale
Interval 11.4 to 23.6

Adverse Events

Conservative Treatment of Hemmorhoid

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Combined Treatment of Hemmorhoid

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Surgical Treatment of Hemmorhoid

Serious events: 1 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Conservative Treatment of Hemmorhoid
n=311 participants at risk
Patients taken conservative treatment (Detralex) Detralex: Conservative treatment of Hemorhoid
Combined Treatment of Hemmorhoid
n=298 participants at risk
Combined treatment patients (surgery and conservative treatment) Combined therapy: Surgical + conservative treatment of Hemorhoid
Surgical Treatment of Hemmorhoid
n=423 participants at risk
Patients after surgical treatment (Instrumental Invasive Surgical Procedures or Thrombectomy, Hemorrhoidectomy etc.) Hemorrhoidectomy, Thrombectomy , Operation on Longo method: Surgical procedures for treatment of Hemorhoid
Gastrointestinal disorders
Diarrhea
0.00%
0/311 • 3 months
0.00%
0/298 • 3 months
0.24%
1/423 • Number of events 1 • 3 months

Other adverse events

Adverse event data not reported

Additional Information

Olga Linnik

AO Servier

Phone: +7 495 9370700

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place